Skip to content

DF4 Connector System Post-Approval Study

DF4 Connector System Post-Approval Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01638897
Enrollment
1778
Registered
2012-07-12
Start date
2012-01-31
Completion date
2019-03-31
Last updated
2019-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, Sudden Cardiac Death, Ventricular Fibrillation, Ventricular Tachycardia

Keywords

ICD, CRTD, DF4

Brief summary

The purpose of this study is to evaluate long-term performance of the DF4 Connector System. This evaluation is based on the number of DF4 lead-related complications occurring during the study compared to the number of leads enrolled in the study. The DF4 systems will be followed for 5 years after implant. This study is required by FDA as a condition of approval of the DF4 Connector Systems. This study is conducted within Medtronic's post-market surveillance platform.

Interventions

None listed

Sponsors

Medtronic
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Subject or legally authorized representative provides written authorization and/or consent per institution and geographical requirements * Subject is intended to be implanted or is within 30 days post-implant of a DF4 Connector System with a Medtronic DF4 lead used for a pacing, sensing and/or defibrillation application

Exclusion criteria

* Subject who is, or will be inaccessible for follow-up at a study site * Subject with

Design outcomes

Primary

MeasureTime frameDescription
DF4 Lead Related Complication RateUp to 5 YearsTo demonstrate that the complication-free probability is greater than 92.5% at five years post-implant for the high voltage DF4 lead

Secondary

MeasureTime frameDescription
Types of DF4 lead related eventsUp to 5 yearsNumber of DF4 lead related events grouped by type
Bipolar pacing impedance (ohms)5 yearsSummary statistics at 5 years post-implant will be reported.
High voltage impedance (ohms)5 yearsSummary statistics at 5 years post-implant will be reported
Pacing threshold (volts)5 yearsThe pacing threshold is the minimum electrical stimulus needed to consistently depolarize the heart outside of the heart's refractory period. Summary statistics at 5 years post-implant will be reported.
Sensing amplitude (millivolts)5 yearsThe amplitude of the intrinsic cardiac electrical signals detected by electrodes on the defibrillator lead will be summarized at 5 years post-implant.

Countries

Canada, France, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026